We are live on
!
Find out more
GQG Partners Portfolio holdings
AUM
$53.8B
1-Year Est. Return
19.23%
This Fund
S&P 500
This Quarter
Est. Return
+10.61%
1 Year Est. Return
+19.23%
3 Year Est. Return
+225.42%
5 Year Est. Return
+476.53%
10 Year Est. Return
–
AUM
$2.85B
AUM Growth
+$1.49B
(+109%)
Cap. Flow
+$1.32B
Cap. Flow
% of AUM
46.27%
Top 10 Holdings %
Top 10 Hldgs %
52.75%
Holding
61
New
11
Increased
39
Reduced
3
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$106M |
| 2 |
Meta Platforms (Facebook)
META
|
+$101M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$87.6M |
| 4 |
Alibaba
BABA
|
+$87.1M |
| 5 |
UnitedHealth
UNH
|
+$86M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Grupo Cibest SA
CIB
|
+$29.5M |
| 2 |
Pampa Energía
PAM
|
+$22.4M |
| 3 |
Credicorp
BAP
|
+$6.42M |
| 4 |
GE Aerospace
GE
|
+$5.27M |
| 5 |
SLB Ltd
SLB
|
+$4.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 22.03% |
| 2 | Financials | 21.25% |
| 3 | Healthcare | 17.97% |
| 4 | Consumer Discretionary | 17.64% |
| 5 | Technology | 15.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Microsoft
MSFT
$3.75T
| $544K | 0.02% |
7,309
-261
| -3% | -$19.1K |
|
|
NVO
52
Novo Nordisk
NVO
$205B
| $491K | 0.02% |
20,400
| – | – |
|
53
UBS Group
UBS
$166B
| $405K | 0.01% |
+23,642
| New | +$404K |
|
|
RDS.A
54
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $328K | 0.01% |
5,414
| – | – |
|
55
Novartis
NVS
$294B
| $261K | 0.01% |
3,393
-1,517
| -31% | -$115K |
|
56
Comcast
CMCSA
$93.7B
| $205K | 0.01% |
5,334
| – | – |
|
|
57
Grupo Cibest SA
CIB
$23.3B
| – | – |
-662,427
| Closed | -$29.5M |
|
|
58
GE Aerospace
GE
$356B
| – | – |
-40,736
| Closed | -$5.27M |
|
|
59
Pampa Energía
PAM
$4.35B
| – | – |
-380,745
| Closed | -$22.4M |
|
60
Shinhan Financial Group
SHG
$36.6B
| – | – |
-84,839
| Closed | -$3.69M |
|
|
61
SLB Ltd
SLB
$81.6B
| – | – |
-65,508
| Closed | -$4.31M |
|
Similar funds
HF
GQG Partners's Q3 2017 Portfolio in Review
As of Q3 2017, GQG Partners held 61 positions worth $2.85B, up 109% from $1.36B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
GQG Partners deployed $1.32B of net new capital in Q3 2017, opening 11 new positions and adding to 39 existing holdings. Its largest new stake was Allergan plc: 454,627 shares worth $93.2M.
By sector, the portfolio is most concentrated in Communication Services at 22% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Credicorp, an estimated $6.42M trimmed.
- GQG Partners's largest Q3 2017 buy was Allergan plc: 454,627 shares worth $93.2M.
- GQG Partners added most to Meta Platforms (Facebook) in Q3 2017, an estimated $101M increase.
- GQG Partners's biggest Q3 2017 reduction was Credicorp, cutting an estimated $6.42M.
- GQG Partners fully exited Grupo Cibest SA in Q3 2017, selling an estimated $29.5M.
- GQG Partners's ten largest holdings make up 53% of its $2.85B portfolio in Q3 2017.
- GQG Partners opened 11 new positions and closed 5 in Q3 2017.
- GQG Partners's portfolio value rose 109% quarter-over-quarter to $2.85B.
Based on GQG Partners's 13F filing for Q3 2017, filed 13 Nov 2017.